Bacterial biofilms and chronic rhinosinusitis

Allergy and Asthma Proceedings

Volumn 34, Issue 4, 2013, Pages 335-341

  Madeo, Jennifer ^a   Frieri, Marianne ^a,b  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CLARITHROMYCIN; ERYTHROMYCIN; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 8; MACROLIDE; NITRIC OXIDE; THIAMPHENICOL; TUMOR NECROSIS FACTOR ALPHA;

ACUTE RHINOSINUSITIS; ACUTE SINUSITIS; ALLERGIC RHINITIS; ANTIBIOTIC SENSITIVITY; ARTICLE; ASTHMA; BACTERIAL BIOFILM; BACTERIAL CELL; BIOFILM; BRONCHIECTASIS; CHRONIC RHINOSINUSITIS; CHRONIC SINUSITIS; CILIARY DYSKINESIA; COMMUNICABLE DISEASE; CYSTIC FIBROSIS; ENDOSCOPIC SINUS SURGERY; EXTRACELLULAR FLUID; HOSPITAL INFECTION; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; LOW DRUG DOSE; MICROBIAL COMMUNITY; MICROBIAL GENETICS; MUCOCILIARY TRANSPORT; NONHUMAN; NOSE ALLERGY; NOSE POLYP; PARANASAL SINUS; PHENOTYPE; PHOTODYNAMIC THERAPY; POLYPECTOMY; PROGNOSIS; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; RHINOPHARYNGITIS; SINUSITIS; SMOOTH MUSCLE RELAXATION; STAPHYLOCOCCUS AUREUS; VASODILATATION;

BIOFILMS; CHRONIC DISEASE; EXOTOXINS; HUMANS; NASAL MUCOSA; RHINITIS; SINUSITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 84878231978     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2013.34.3665     Document Type: Article

References (107)

1. National Center for Health Statistics (NCHS) Summary Health Statistics for US Adults: Chronic sinusitis. Hyattsville, MD: National Center for Health Statistics, Sondik EJ and Madans J, 1-219, 2001.
2. Soler ZM, Mace JC, Litvack JR, and Smith TL. Chronic rhinosinusitis, race, and ethnicity. Am J Rhinol Allergy 26:110-116, 2012.
3. Pleis JR, and Lucas JW. Summary health statistics for U.S. adults: National Health Interview Survey, 2007. Vital Health Stat 10:1-159, 2009.
4. Goetzel RZ, Hawkins K, Ozminkowski RJ, and Wang S. The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999. J Occup Environ Med 45:5-14, 2003.
5. Bhattacharyya N. Functional limitations and workdays lost associated with chronic rhinosinusitis and allergic rhinitis. Am J Rhinol Allergy 26:120-122, 2012.
6. Brook I. Microbiology and antimicrobial treatment of orbital and intracranial complications of sinusitis in children and their management. Int J Pediatr Otorhinolaryngol 73:1183-1186, 2009.
7. Tamashiro E, Antunes MB, Palmer JN, et al. Implications of bacterial biofilms in chronic rhinosinusitis. Braz J Infect Dis 13:232-235, 2009.
8. Cryer J, Schipor I, Perloff JR, and Palmer JN. Evidence of bacterial biofilms in human chronic sinusitis. ORL J Otorhinolaryngol Relat Spec 66:155-158, 2004.
9. Sanclement JA, Webster P, Thomas J, and Ramadan HH. Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope 115:578-582, 2005.
10. Kilty SJ, and Desrosiers MY. Are biofilms the answer in the pathophysiology and treatment of chronic rhinosinusitis? Immunol Allergy Clin North Am 29:645-656, 2009.
11. Hoiby N, Ciofu O, Johansen HK, et al. The clinical impact of bacterial biofilms. Int J Oral Sci 3:55-65, 2011.
12. Donlan RM, and Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193, 2002.
13. Psaltis AJ, Weitzel EK, Ha KR, and Wormald PJ. The effect of bacterial biofilms on post-sinus surgical outcomes. Am J Rhinol 22:1-6, 2008.
14. Foreman A, Boase S, Psaltis A, and Wormald PJ. Role of bacterial and fungal biofilms in chronic rhinosinusitis. Curr Allergy Asthma Rep 12:127-135, 2012.
15. Jardeleza C, Foreman A, Baker L, et al. The effects of nitric oxide on Staphylococcus aureus biofilm growth and its implications in chronic rhinosinusitis. Int Forum Allergy Rhinol 1:438-444, 2011.
16. You HH, Zhuge P, Shi HM, et al. Observation of bacterial biofilms in patients with chronic rhinosinusitis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 46:547-551, 2011.
17. De Kievit TR, Gillis R, Marx S, et al. Quorum-sensing genes in Pseudomonas aeruginosa biofilms: Their role and expression patterns. Appl Environ Microbiol 67:1865-1873, 2001.
18. Costerton W, Veeh R, Shirtliff M, et al. The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 112:1466-1477, 2003.
19. Lellouche J, Friedman A, Gedanken A, and Banin E. Antibacterial and antibiofilm properties of yttrium fluoride nanoparticles. Int J Nanomedicine 7:5611-5624, 2012.
20. Syed S, Zubair A, and Frieri M. Immune response to nanomaterials: Implications for medicine and literature review. Curr Allergy Asthma Rep 1:50-57, 2012.
21. von Eiff C, Becker K, Machka K, et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 344:11-16, 2001.
22. Quinn GA, and Cole AM. Suppression of innate immunity by a nasal carriage strain of Staphylococcus aureus increases its colonization on nasal epithelium. Immunology 122:80-89, 2007.
23. Singhal D, Boase S, Field J, et al. Quantitative analysis of in vivo mucosal bacterial biofilms. Int Forum Allergy Rhinol 2:57-62, 2012.
24. Cole AM, Tahk S, Oren A, et al. Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol 8:1064-1069, 2001.
25. Secor PR, James GA, Fleckman P, et al. Staphylococcus aureus biofilm and planktonic cultures differentially impact gene expression, mapk phosphorylation, and cytokine production in human keratinocytes. BMC Microbiol 11:143, 2011.
26. Quinn GA, Tarwater PM, and Cole AM. Subversion of interleukin-1-mediated host defence by a nasal carrier strain of Staphylococcus aureus. Immunology 128:e222-e229, 2009.
27. Muthukrishnan G, Quinn GA, Lamers RP, et al. Exoproteome of Staphylococcus aureus reveals putative determinants of nasal carriage. J Proteome Res 10:2064-2078, 2011.
28. Krismer B, and Peschel A. Does Staphylococcus aureus nasal colonization involve biofilm formation? Future Microbiol 6:489-493, 2011.
29. Lane AP, Truong-Tran QA, and Schleimer RP. Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps. Am J Rhinol 20:138-144, 2006.
30. Nakayama T, Asaka D, Yoshikawa M, et al. Identification of chronic rhinosinusitis phenotypes using cluster analysis. Am J Rhinol Allergy 26:172-176, 2012.
31. Mithani SFS, Frieri M, and Bonagura V. Mannose-binding lectin and IgA deficiency with anti-IgA antibodies. Ann Allergy Asthma Immunol 105:182, 2010.
32. Bensch GW, Nelson HS, and Borish LC. Evaluation of cytokines in nasal secretions after nasal antigen challenge: Lack of influence of antihistamines. Ann Allergy Asthma Immunol 88:457-462, 2002.
33. Bachert C, van Kempen M, and Van Cauwenberge P. Regulation of proinflammatory cytokines in seasonal allergic rhinitis. Int Arch Allergy Immunol 118:375-379, 1999.
34. Plager DA, Kahl JC, Asmann YW, et al. Gene transcription changes in asthmatic chronic rhinosinusitis with nasal polyps and comparison to those in atopic dermatitis. PLoS One 5:e11450, 2010.
35. Bernstein JM, and Kansal R. Superantigen hypothesis for the early development of chronic hyperplastic sinusitis with massive nasal polyposis. Curr Opin Otolaryngol Head Neck Surg 13:39-44, 2005.
36. Bernstein JM, Ballow M, Schlievert PM, et al. A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis. Am J Rhinol 17:321-326, 2003.
37. Bachert C, and Zhang N. Chronic rhinosinusitis and asthma: Novel understanding of the role of IgE "above atopy." J Intern Med 272:133-143, 2012.
38. Van Zele T, Gevaert P, Watelet JB, et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 114:981-983, 2004.
39. Steinke JW, and Borish L. The role of allergy in chronic rhinosinusitis. Immunol Allergy Clin North Am 24:45-57, 2004.
40. Sahin G, Klimek L, Mullol J, et al. Nitric oxide: A promising methodological approach in airway diseases. Int Arch Allergy Immunol 156:352-361, 2011.
41. Kobayashi Y. The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation. J Leukoc Biol 88:1157-1162, 2010.
42. Shusterman DJ, Weaver EM, Goldberg AN, et al. Pilot evaluation of the nasal nitric oxide response to humming as an index of osteomeatal patency. Am J Rhinol Allergy 26:123-126, 2012.
43. Frieri M. The role of cytokines in asthma. Asthma Manage 2:25-31, 1993.
44. Frieri M. Nitric oxide in allergic rhinitis and asthma. Allergy Asthma Proc 19:349-351, 1998.
45. Yuksel H, Kirmaz C, Yilmaz O, et al. Nasal mucosal expression of nitric oxide synthases in patients with allergic rhinitis and its relation to asthma. Ann Allergy Asthma Immunol 100:12-16, 2008.
46. Suzuki H, Takahashi Y, Wataya H, et al. Mechanism of neutrophil recruitment induced by IL-8 in chronic sinusitis. J Allergy Clin Immunol 98:659-670, 1996.
47. Frieri M, Therattil J, Chavarria V, et al. Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 81:431-437, 1998.
48. Frieri MMJ, and Zitt M. Late phase inflammation during nasal grass and ragweed challenge in a double-blind placebo controlled trial with astemizole. Am J Rhinol Allergy 3:1-5, 1995.
49. Hanazawa T, Antuni JD, Kharitonov SA, and Barnes PJ. Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis. J Allergy Clin Immunol 105:58-64, 2000.
50. Kamekura R, Kojima T, Takano K, et al. The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis. Clin Exp Allergy 42:218-228, 2012.
51. Rolla G, Heffler E, Bommarito L, et al. Exhaled nitric oxide as a marker of diseases. Recenti Prog Med 96:634-640, 2005.
52. Jardeleza C, Jones D, Baker L, et al. Gene expression differences in nitric oxide and reactive oxygen species regulation point to an altered innate immune response in chronic rhinosinusitis. Int Forum Allergy Rhinol 2012 (DOI: 10.1002/alr.21114)
53. Scadding G, and Scadding GK. Update on the use of nitric oxide as a noninvasive measure of airways inflammation. Rhinology 47:115-120, 2009.
54. Khanduja KL, Kaushik G, Khanduja S, et al. Corticosteroids affect nitric oxide generation, total free radicals production, and nitric oxide synthase activity in monocytes of asthmatic patients. Mol Cell Biochem 346:31-37, 2011.
55. Deroee AF, Naraghi M, Sontou AF, et al. Nitric oxide metabolites as biomarkers for follow-up after chronic rhinosinusitis surgery. Am J Rhinol Allergy 23:159-161, 2009.
56. Ciprandi G, Tosca MA, and Capasso M. Exhaled nitric oxide in children with allergic rhinitis and/or asthma: A relationship with bronchial hyperreactivity. J Asthma 47:1142-1147, 2010.
57. Olin AC. Induced sputum, exhaled nitric oxide, and particles in exhaled air in assessing airways inflammation in occupational exposures. Clin Chest Med 33:771-782, 2012.
58. Murphy AW, Platts-Mills TA, Lobo M, and Hayden F. Respiratory nitric oxide levels in experimental human influenza. Chest 114:452-456, 1998.
59. Matsunaga K, Yanagisawa S, Hirano T, et al. Associated demographics of persistent exhaled nitric oxide elevation in treated asthmatics. Clin Exp Allergy 42:775-781, 2012.
60. Kharitonov SA, Rajakulasingam K, O'Connor B, et al. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol 99:58-64, 1997.
61. Bazeghi N, Gerds TA, Budtz-Jorgensen E, et al. Exhaled nitric oxide measure using multiple flows in clinically relevant subgroups of COPD. Respir Med 105:1338-1344, 2011.
62. Tataurshchikova NS, and Sidorovich IG. The cytokine status as a criterion for the efficacy of intranasal aerosol therapy with the use of a cycloferon solution in the patients presenting with allergic rhinosinusitis. Vestn Otorinolaringol 2012:79-82.
63. Narayan AR, Huang YC, Wang XP, et al. Aeruginosa lipopolysaccharide (PsLPS) and A. fumigatus (Asp) stimulated TNF-α, RANTES and nitric oxide (NO) from peripheral blood mononuclear cells (PBMCs) from cystic fibrosis (CF) patients with bronchial epithelial cells (BECs): Modulation by rhDNase. J Allergy Clin Immunol 115:S221, 2005.
64. Kim YH, and Jang TY. Clinical characteristics and therapeutic outcomes of patients with localized mucosal allergy. Am J Rhinol Allergy 24:e89-e92, 2010.
65. Vosswinkel R, Neidt I, and Bothe H. The production and utilization of nitric oxide by a new, denitrifying strain of Pseudomonas aeruginosa. Arch Microbiol 156:62-69, 1991.
66. Heiss LN, Lancaster JR Jr, Corbett JA, and Goldman WE. Epithelial autotoxicity of nitric oxide: Role in the respiratory cytopathology of pertussis. Proc Natl Acad Sci U S A 91:267-270, 1994.
67. Kaliner MA, Osguthorpe JD, Fireman P, et al. Sinusitis: Bench to bedside. Current findings, future directions. J Allergy Clin Immunol 99:S829-S848, 1997.
68. Zhang Y, Endam LM, Filali-Mouhim A, et al. Polymorphisms in the nitric oxide synthase 1 gene are associated with severe chronic rhinosinusitis. Am J Rhinol Allergy 25:e49-e54, 2011.
69. Georgy MS, and Peters AT. Chapter 8: Rhinosinusitis. Allergy Asthma Proc 33(suppl 1):S24-S27, 2012.
70. Payne SC, Borish L, and Steinke JW. Genetics and phenotyping in chronic sinusitis. J Allergy Clin Immunol 128:710-720, 2011.
71. Leung RS, and Katial R. The diagnosis and management of acute and chronic sinusitis. Prim Care 35:11-24, v-vi, 2008.
72. Marseglia GL, Caimmi D, Pagella F, et al. Adenoids during childhood: The facts. Int J Immunopathol Pharmacol 24:1-5, 2011.
73. Ryan WR, Ramachandra T, and Hwang PH. Correlations between symptoms, nasal endoscopy, and in-office computed tomography in post-surgical chronic rhinosinusitis patients. Laryngoscope 121:674-678, 2011.
74. Tosca MA, Riccio AM, Marseglia GL, et al. Nasal endoscopy in asthmatic children: assessment of rhinosinusitis and adenoiditis incidence, correlations with cytology and microbiology. Clin Exp Allergy 31:609-615, 2001.
75. Frieri M. In Chronic Sinusitis and Steroid Unresponsive Cough-Induced Asthma. Presented at the North American Rhinology and Allergy Conference, Puerto Rico, February 3-5, 2012.
76. Frieri M. In Chronic Rhinosinusitis with an Uncommon Immune Deficiency. Presented at the North American Rhinology and Allergy Conference, Puerto Rico, February 3, 2011.
77. Torre D, Broggini M, Botta V, et al. In vitro and ex vivo effects of recent and new macrolide antibiotics on chemotaxis of human polymorphonuclear leukocytes. J Chemother 3:236-239, 1991.
78. Sacks PLT, Harvey RJ, Rimmer J, et al. Antifungal therapy in the treatment of chronic rhinosinusitis: A meta-analysis. Am J Rhinol Allergy 26:141-147, 2012.
79. Haruna S, Shimada C, Ozawa M, et al. A study of poor responders for long-term, low-dose macrolide administration for chronic sinusitis. Rhinology 47:66-71, 2009.
80. Zeng M, Long XB, Cui YH, and Liu Z. Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in Chinese adults. Am J Rhinol Allergy 25:e203-e207, 2011.
81. Leung R, Chaung K, Kelly JL, and Chandra RK. Advancements in computed tomography management of chronic rhinosinusitis. Am J Rhinol Allergy 25:299-302, 2011.
82. Biel MA, Sievert C, Usacheva M, et al. Antimicrobial photodynamic therapy treatment of chronic recurrent sinusitis biofilms. Int Forum Allergy Rhinol 1:329-334, 2011.
83. Varricchio A, Capasso M, Di Gioacchino M, and Ciprandi G. Inhaled thiamphenicol and acetylcysteine in children with acute bacterial rhinopharyngitis. Int J Immunopathol Pharmacol 21: 625-629, 2008.
84. Serra A, Schito GC, Nicoletti G, and Fadda G. A therapeutic approach in the treatment of infections of the upper airways: Thiamphenicol glycinate acetylcysteinate in sequential treatment (systemic-inhalatory route). Int J Immunopathol Pharmacol 20:607-617, 2007.
85. Patel ZM, Hwang PH, Chernomorsky A, et al. Low-frequency pulsed ultrasound in the nasal cavity and paranasal sinuses: A feasibility and distribution study. Int Forum Allergy Rhinol 2:303-308, 2012.
86. Asaka D, Nakayama T, Hama T, et al. Risk factors for complications of endoscopic sinus surgery for chronic rhinosinusitis. Am J Rhinol Allergy 26:61-64, 2012.
87. Tan NC, Foreman A, Jardeleza C, et al. The multiplicity of Staphylococcus aureus in chronic rhinosinusitis: Correlating surface biofilm and intracellular residence. Laryngoscope 122: 1655-1660, 2012.
88. Singhal D, Foreman A, Jervis-Bardy J, et al. Staphylococcus aureus biofilms: Nemesis of endoscopic sinus surgery. Laryngoscope 121:1578-1583, 2011.
89. Moshaver A, Velazquez-Villasenor L, Lavigne F, and Witterick IJ. Selective irrigation of paranasal sinuses in the treatment of recalcitrant chronic sinusitis. Am J Rhinol Allergy 24:371-373, 2010.
90. Ragab A, Essa N, El-Raghy N, et al. Evaluation of bacterial adherence and biofilm arrangements as new targets in treatment of chronic rhinosinusitis. Eur Arch Otorhinolaryngol 269: 537-544, 2012.
91. Karosi T, Csomor P, and Sziklai I. Tumor necrosis factor-alpha receptor expression correlates with mucosal changes and biofilm presence in chronic rhinosinusitis with nasal polyposis. Laryngoscope 122:504-510, 2012.
92. Calus L, Van Zele T, Derycke L, et al. Local inflammation in chronic upper airway disease. Curr Pharm Des 18:2336-2346, 2012.
93. Li H, Wang D, Sun X, et al. Relationship between bacterial biofilm and clinical features of patients with chronic rhinosinusitis. Eur Arch Otorhinolaryngol 269:155-163, 2012.
94. You H, Zhuge P, Li D, et al. Factors affecting bacterial biofilm expression in chronic rhinosinusitis and the influences on prognosis. Am J Otolaryngol 32:583-590, 2011.
95. Lin DC, Chandra RK, Tan BK, et al. Association between severity of asthma and degree of chronic rhinosinusitis. Am J Rhinol Allergy 25:205-208, 2011.
96. 2LEN survey in Europe. Allergy 67:91-98, 2012.
97. Perloff JR, and Palmer JN. Evidence of bacterial biofilms in a rabbit model of sinusitis. Am J Rhinol 19:1-6, 2005.
98. Ha KR, Psaltis AJ, Tan L, and Wormald PJ. A sheep model for the study of biofilms in rhinosinusitis. Am J Rhinol 21:339-345, 2007.
99. Boase S, Valentine R, Singhal D, et al. A sheep model to investigate the role of fungal biofilms in sinusitis: Fungal and bacterial synergy. Int Forum Allergy Rhinol 1:340-347, 2011.
100. Singhal D, Jekle A, Debabov D, et al. Efficacy of NVC-422 against Staphylococcus aureus biofilms in a sheep biofilm model of sinusitis. Int Forum Allergy Rhinol 2:309-315, 2012.
101. Thebaud B, Arnal JF, Mercier JC, and Dinh-Xuan AT. Inhaled and exhaled nitric oxide. Cell Mol Life Sci 55:1103-1112, 1999.
102. Shargorodsky J, and Bhattacharyya N. What is the role of nasal endoscopy in the diagnosis of chronic rhinosinusitis? Laryngoscope 123:4-6, 2013.
103. Raithatha R, Anand VK, Mace JC, et al. Interrater agreement of nasal endoscopy for chronic rhinosinusitis. Int Forum Allergy Rhinol 2:144-150, 2012.
104. Foreman A, Jervis-Bardy J, Boase SJ, et al. Noninvasive Staphylococcus aureus biofilm determination in chronic rhinosinusitis by detecting the exopolysaccharide matrix component poly-Nacetylglucosamine. Int Forum Allergy Rhinol 2:83-88, 2012.
105. Sperandio V. Novel approaches to bacterial infection therapy by interfering with bacteria-to-bacteria signaling. Expert Rev Anti Infect Ther 5:271-276, 2007.
106. Rasko DA, and Sperandio V. Novel approaches to bacterial infection therapy by interfering with cell-to-cell signaling. Curr Protoc Microbiol 2009 (DOI: 10.1002/9780471729259.mc1703s12).
107. Smith A, Buchinsky FJ, and Post JC. Eradicating chronic ear, nose, and throat infections: A systematically conducted literature review of advances in biofilm treatment. Otolaryngol Head Neck Surg 144:338-347, 2011.